Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence

Free Radic Res. 1998 Feb;28(2):179-91. doi: 10.3109/10715769809065803.

Abstract

When differentiated into mature macrophages by the combination of all-trans retinoic acid and 1,25-dihydroxyvitamin D3, the human promonocytic cell lines U937 and THP-1 expressed inducible nitric oxide synthase (iNOS) transcripts. During their differentiation, the cells acquired the capacity to produce not only superoxide anion (O2.-) but also nitric oxide (.NO) in response to IgG (or IgE)-opsonized zymosan. The inhibitors of the iNOS pathway, aminoguanidine and NG-monomethyl-L-arginine (L-NMMA), suppressed the production of .NO and enhanced the steady-state concentration of O2.- determined. Conversely, superoxide dismutase (SOD) scavenged the O2.- released and increased the .NO-derived nitrite concentration detected. These data suggested a possible interaction between O2.- and .NO. In differentiated U937 (or THP-1) cells, IgG or IgE-opsonized zymosan induced a strong time-dependent luminol-dependent chemiluminescence (LDCL), which was abrogated by SOD and partially inhibited by aminoguanidine or L-NMMA. Since the iNOS inhibitors did not directly scavenge O2.-, LDCL determination in the presence or absence of SOD and/or iNOS inhibitors demonstrated a concomitant production of O2.- and .NO. These radicals induced the formation of a .NO-derived product(s), probably peroxynitrite (ONOO-), which was required to elicit maximal LDCL. Finally, LDCL measurement provided a convenient tool to characterize iNOS triggering and demonstrated an interaction between NADPH oxidase and iNOS products in human macrophagic cells phagocytizing opsonized-zymosan. These findings show that in activated macrophages, iNOS activity can be involved in LDCL and support the debated hypothesis of iNOS participation to the microbicidal activity of human macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcitriol / pharmacology
  • Cell Differentiation / drug effects
  • Cell-Free System
  • Free Radical Scavengers
  • Guanidines / pharmacology
  • Humans
  • Immunoglobulin E / metabolism
  • Immunoglobulin G / metabolism
  • Leukemia, Monocytic, Acute / pathology
  • Luminescent Measurements
  • Luminol
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Macrophage Activation
  • Macrophages / metabolism*
  • Neoplastic Stem Cells / drug effects
  • Nitrates / pharmacology
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type II
  • Opsonin Proteins / metabolism
  • Phagocytosis*
  • Superoxide Dismutase / metabolism
  • Superoxides / metabolism
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Xanthine / metabolism
  • Xanthine Oxidase / metabolism
  • Zymosan / metabolism
  • omega-N-Methylarginine / pharmacology

Substances

  • Free Radical Scavengers
  • Guanidines
  • Immunoglobulin G
  • Nitrates
  • Opsonin Proteins
  • Superoxides
  • Xanthine
  • peroxynitric acid
  • omega-N-Methylarginine
  • Nitric Oxide
  • Immunoglobulin E
  • Tretinoin
  • Luminol
  • Zymosan
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Superoxide Dismutase
  • Xanthine Oxidase
  • Calcitriol
  • pimagedine